Clover Health Investments Corp
NASDAQ:CLOV
EV/EBIT
Enterprise Value to EBIT
Enterprise Value to EBIT (EV/EBIT) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s earnings before interest and taxes (EBIT). Considered one of the most frequently used multiples for comparisons among companies, the EV/EBIT multiple relies on operating income as the core driver of valuation.
Market Cap | EV/EBIT | ||||
---|---|---|---|---|---|
US |
Clover Health Investments Corp
NASDAQ:CLOV
|
433.6m USD | -0.7 | ||
US |
UnitedHealth Group Inc
NYSE:UNH
|
476.9B USD | 15.8 | ||
US |
Elevance Health Inc
NYSE:ELV
|
126B USD | 15.8 | ||
US |
Anthem Inc
NYSE:ANTM
|
116.4B USD | 14.7 | ||
US |
Humana Inc
NYSE:HUM
|
42.8B USD | 12.1 | ||
US |
Centene Corp
NYSE:CNC
|
41.6B USD | 11.3 | ||
US |
Molina Healthcare Inc
NYSE:MOH
|
20.3B USD | 8.5 | ||
US |
Healthequity Inc
NASDAQ:HQY
|
6.8B USD | 57 | ||
BR |
Hapvida Participacoes e Investimentos SA
BOVESPA:HAPV3
|
34.1B BRL | 26.2 | ||
BR |
Notre Dame Intermedica Participacoes SA
OTC:NTEDY
|
6.4B USD | 23.8 | ||
US |
Progyny Inc
NASDAQ:PGNY
|
2.7B USD | 35.3 |
EV/EBIT Forward Multiples
Forward EV/EBIT multiple is a version of the EV/EBIT ratio that uses forecasted EBIT for the EV/EBIT calculation. 1-Year, 2-Years, and 3-Years forwards use EBIT forecasts for 1, 2, and 3 years ahead, respectively.